Semax dosage numbers are everywhere and they trace back to two places: clinical practice inside Russia, where the compound is a registered medicine, and vendor pages that repeat each other. Neither source was measuring muscle. No study in any organism has administered this peptide and recorded lean mass, strength or body fat, so no amount in circulation was ever chosen with those outcomes in mind.
The vendor we point lifters to
Semax from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
This article is about where the figures come from, what they can legitimately support, and why the most important risk in the whole dosing conversation is not the number at all. It contains no protocol, because publishing one would mean inventing the evidence to justify it.
Where a Semax dosage figure comes from, and where it does not
Three origins account for nearly everything you will read.
The first is Russian clinical practice. There the compound is a registered pharmaceutical with prescribing conventions attached to it, and amounts used in that setting are real amounts used by doctors treating patients. They were selected for neurological and cognitive indications, in patients, under supervision, using a manufactured pharmaceutical product.
The second is vendor copy. Suppliers selling research chemicals attach ranges to listings because a listing without one converts badly. These ranges are frequently presented with a precision that implies a source, and the source is usually another vendor page.
The third is forum consensus, which is the first two laundered through repetition until the original attribution is gone. By the time a figure reaches a comment thread it carries no organism, no indication and no route, and it looks like a fact.
The route problem that sits under every number
The compound is used as a nasal preparation in the setting where it is a medicine. That single detail invalidates most of the arithmetic people do with it.
An amount delivered into the nose and an amount injected are not interchangeable quantities, because the fraction that reaches the circulation and the tissue differs by route, and for peptides that difference is not small or predictable from first principles. A figure lifted from clinical practice and applied to a vial of powder bought online is not a conversion. It is a number that has changed meaning while keeping its digits.
This is worth dwelling on because the research chemical market mostly sells vials, while the clinical record mostly describes drops. People bridge that gap with confidence they have not earned, and the bridge is invisible in the finished sentence.
Why there is no amount aimed at lean mass
A dose is not a property of a molecule. It is the output of a study that gave different amounts and measured a defined outcome, then identified where benefit and harm crossed.
For lean mass, that study has not been run in any organism. No rodent experiment has dosed this compound and weighed muscle. No cell culture work has been done on muscle tissue. No human study has measured body composition after administration. Without an endpoint there is no dose response, and without a dose response there is no dose, only a quantity.
So the honest answer to "how much for muscle" is not a range with caveats. It is that the question has no denominator. Anyone supplying a figure is either repeating a number chosen for the brain or making one up.
Figure, origin, and what it can actually support
| Where a number comes from | What it was chosen for | Organism | What it can support |
|---|---|---|---|
| Russian clinical practice | Neurological and cognitive indications | Human | Use of a manufactured medicine, in that system, by that route |
| Animal neuroscience studies | Brain and behavioural endpoints | Rat | Interpretation of that animal result only |
| Vendor listings | Selling a vial | None | Nothing |
| Forum consensus | Repetition | None | Nothing |
| Body composition research | Does not exist | None | Nothing |
The bottom row is the one that decides the topic for this audience.
What the animal work specified instead
Rodent studies of this compound were built around nervous system outcomes: behavioural measures, tissue changes, injury models, expression of neurotrophic factors in rat brain. Amounts in that work were selected to produce a detectable brain effect in a rat, over the timescale of the experiment.
Those amounts are study parameters, not recommendations, and they do not scale to people by body weight arithmetic. Species differ in how quickly peptides are cleared, in how much reaches the target tissue and in what the tissue does with it. A rat number divided by a rat and multiplied by a person is a calculation with no biology in it.
More to the point for this site, none of those experiments measured a muscle. Scaling a number correctly would still leave you with an amount tested against an outcome nobody here cares about.
How long, as opposed to how much
Almost every discussion of amounts skips the second half of a dosing question, which is duration. In clinical use a medicine is given for a defined period tied to an indication, and that period is part of the evidence. Take the period away and the amount stops meaning anything, because a quantity given once and the same quantity given for months are different exposures.
For this compound the durations that exist belong to Russian medical practice and to animal experiments, and both were set by the outcome being measured. A course aimed at a neurological indication ends when the indication is addressed. A rodent experiment ends when the behavioural or tissue measurement is taken.
Neither of those tells a lifter anything about continued use in a healthy person over a training year. That question has not been studied in any organism: there is no long term human safety data outside the Russian clinical setting, no animal work on prolonged administration in healthy subjects, and nothing at all on what months of exposure would do to training or body composition.
So a reader who has settled on a number still has no defensible answer to how long, and the second gap is the larger one. Open ended use of an unapproved compound, on the strength of a duration nobody established, is the part of this conversation that gets the least attention and probably deserves the most.
The dosing questions that keep recurring
Is there a correct Semax dosage for a healthy adult?
Not one established by research a reader can check. Amounts exist in Russian clinical use for defined medical indications, which is a different question from what a healthy lifter should take, and that second question has not been studied.
Can a nasal amount be converted to an injection?
Not reliably. Bioavailability differs by route and the difference has not been characterised in a way that supports a conversion for this compound.
Would a larger amount produce a bigger effect on training?
There is no measured training effect at any amount in any organism, so there is nothing for a larger amount to increase.
Why do vendor pages give such specific ranges?
Because precision reads as authority. Specificity in a number tells you nothing about whether a study produced it.
Is the real risk the amount or the vial?
For most buyers outside Russia, the vial. What arrives is not the registered medicine, and its identity, purity and quantity rest on the seller's word.
The part of the dosing conversation that is not about numbers
The discussion online is almost entirely about how much, and that is the wrong axis for anyone buying this outside Russia.
Inside Russia a patient receives a manufactured pharmaceutical whose contents are established by the manufacturing process and a regulator. Outside Russia a buyer receives a powder from a supplier, with a stated identity, a stated purity and a stated quantity, all attested by the party being paid. Independent verification is rare, and a mislabelled quantity makes every downstream calculation meaningless regardless of how carefully it was performed.
That is why the dosing question and the sourcing question cannot be separated here. Getting the number right on a substance of unknown content is not precision, it is the appearance of precision, and it is the most common failure mode in this entire market.
There is a second point specific to a body composition audience. Even a perfectly sourced product, dosed exactly as a Russian clinician would dose the medicine, has no established effect on muscle in any organism. The dosing conversation assumes an outcome that has not been demonstrated. Fixing the numbers does not fix that.